CHARLES SCHWAB INVESTMENT MANAGEMENT INC - TARO PHARMACEUTICAL INDS LTD ownership

TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 85 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of TARO PHARMACEUTICAL INDS LTD
ValueSharesWeighting
Q3 2023$704,951
-0.6%
18,6940.0%0.00%
Q2 2023$709,063
-74.9%
18,694
-51.5%
0.00%
-100.0%
Q4 2020$2,830,000
+40.9%
38,541
+5.3%
0.00%0.0%
Q3 2020$2,008,000
-18.8%
36,598
-1.5%
0.00%0.0%
Q2 2020$2,472,000
-12.8%
37,166
-19.7%
0.00%
-50.0%
Q1 2020$2,835,000
-16.9%
46,308
+19.4%
0.00%0.0%
Q4 2019$3,410,000
+21.4%
38,778
+4.1%
0.00%0.0%
Q3 2019$2,810,000
-3.1%
37,234
+9.7%
0.00%0.0%
Q2 2019$2,900,000
-21.2%
33,944
-0.3%
0.00%0.0%
Q1 2019$3,681,000
+305.4%
34,047
+217.7%
0.00%
+100.0%
Q4 2018$908,000
-9.7%
10,717
+4.8%
0.00%0.0%
Q3 2018$1,006,000
-13.3%
10,230
+2.0%
0.00%0.0%
Q2 2018$1,160,000
+47.2%
10,026
+25.8%
0.00%0.0%
Q1 2018$788,000
+36.6%
7,972
+44.9%
0.00%
Q4 2017$577,000
-21.5%
5,502
-15.5%
0.00%
-100.0%
Q3 2017$735,000
+35.1%
6,514
+34.3%
0.00%0.0%
Q2 2017$544,000
+31.4%
4,850
+36.9%
0.00%
Q1 2017$414,000
+10.7%
3,5440.0%0.00%
Q4 2016$374,000
-90.6%
3,544
-90.1%
0.00%
-100.0%
Q3 2016$3,973,000
-51.2%
35,944
-35.8%
0.01%
-50.0%
Q2 2016$8,146,000
+2798.9%
55,944
+2754.3%
0.01%
Q1 2016$281,000
-7.3%
1,9600.0%0.00%
Q4 2015$303,000
-65.9%
1,960
-67.3%
0.00%
-100.0%
Q4 2014$888,000
-3.7%
5,9880.0%0.00%
-50.0%
Q3 2014$922,000
-34.2%
5,988
-40.0%
0.00%0.0%
Q2 2014$1,401,000
+107.2%
9,988
+64.1%
0.00%
+100.0%
Q1 2014$676,0006,0880.00%
Other shareholders
TARO PHARMACEUTICAL INDS LTD shareholders Q4 2020
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 545,583$34,715,00010.89%
Murchinson Ltd. 100,000$6,363,0003.16%
Eversept Partners, LP 179,366$11,413,0590.79%
BRANDES INVESTMENT PARTNERS, LP 266,560$16,962,0000.37%
Analyst IMS Investment Management Services Ltd. 22,755$1,447,0000.18%
Claret Asset Management Corp 9,336$594,0000.10%
ACADIAN ASSET MANAGEMENT LLC 344,023$21,851,0000.08%
Renaissance Technologies 720,500$45,845,0000.06%
C M BIDWELL & ASSOCIATES LTD 1,155$73,0000.05%
First Trust Direct Indexing L.P. 3,357$214,0000.03%
View complete list of TARO PHARMACEUTICAL INDS LTD shareholders